✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Zenith Drugs Ltd.

ZENITHDRUG

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹114 Cr.
P/E
11.91

Zenith Drugs Ltd.

  • Zenith Drugs
  • Amwill Health Care
  • Mangalam Drugs&Org.

FAQs on Zenith Drugs Ltd. Shareprice

Zenith Drugs has given lower returns compared to its competitors.
Zenith Drugs has grown at ~-55.91% over the last 1yrs while peers have grown at a median rate of -36.0%

Zenith Drugs is not expensive.
Latest PE of Zenith Drugs is 11.15, while 3 year average PE is 16.08.
Also latest EV/EBITDA of Zenith Drugs is 6.33 while 3yr average is 6.63.

View FAQ's On Business

Growth Table

  • Zenith Drugs Ltd.
  • Amwill Health Care
  • Mangalam Drugs&Org.

Balance Sheet

  • Zenith Drugs Ltd.
  • Amwill Health Care
  • Mangalam Drugs&Org.

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Zenith Drugs Ltd.
  • Amwill Health Care
  • Mangalam Drugs&Org.

Cash Flow

  • Zenith Drugs Ltd.
  • Amwill Health Care
  • Mangalam Drugs&Org.

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Zenith Drugs Ltd.
  • Amwill Health Care
  • Mangalam Drugs&Org.

Quarterly Results

  • Zenith Drugs Ltd.
  • Amwill Health Care
  • Mangalam Drugs&Org.

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Zenith Drugs Ltd. Financials

Balance sheet of Zenith Drugs is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Zenith Drugs is decreasing.
Latest net debt of Zenith Drugs is ₹7.14 Crs as of Mar-24.
This is less than Mar-23 when it was ₹25.62 Crs.

Yes, profit is increasing.
The profit of Zenith Drugs is ₹9.59 Crs for Mar 2024, ₹4.88 Crs for Mar 2023 and ₹3.14 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Zenith Drugs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech